The Full Phase 3 Data Doesn’t Only Shows Efficacy but Also Means Safety &long-term ... - Latest Tweet by ANI

The full phase 3 data doesn’t only shows efficacy but also means safety &long-term immunogenicity which is at least followed up for next 3-6 months. So, for the full report to be published in a peer-reviewed journal will take at least 4-5 months: Dr Sharvil Patel, MD, Zydus Group pic.twitter.com/qZArr86Csc— ANI (@ANI) August 21, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)